des Varannes S Bruley, Mion F, Ducrotté P, Zerbib F, Denis P, Ponchon T, Thibault R, Galmiche J P
Institut des Maladies de l'Appareil Digestif, CHU- Hôtel Dieu, Nantes, France.
Gut. 2005 Dec;54(12):1682-6. doi: 10.1136/gut.2005.066274. Epub 2005 Apr 20.
Oesophageal pH monitoring is a useful test for the diagnosis of gastro-oesophageal reflux disease (GORD) but has some limitations related to the nasopharyngeal electrode. Recently, a telemetric catheter free system (CFS) (Bravo; Medtronic) was developed. The aim of this study was to determine the concordance of data between the conventional pH measurement system (CPHMS) and the CFS Bravo.
Forty patients with symptoms suggestive of GORD underwent 24 hour oesophageal pH monitoring using the CPHMS with a nasopharyngeal electrode and the Bravo CFS simultaneously. The sensitive tips of both electrodes were positioned at the same level under fluoroscopy. In addition to automatic analysis, each reflux episode was checked visually and characterised.
There was a significant correlation (r = 0.87, p < 0.0001) between the 24 hour oesophageal acid exposures recorded by the CPHMS and the CFS. Twenty four hour oesophageal acid exposure was significantly lower with the CFS than with the CPHMS (2.4 (0.4-8.7) v 3.6 (0.7-8.6); p < 0.0001). Consequently, with the CFS, the cut off level for the diagnosis of GORD, as calculated from the regression equation, was 2.9% (for the 4.2% cut off determined in controls with the CPHMS). After this adjustment, concordance of the diagnosis of GORD was 88% (kappa 0.760). Diagnosis of GORD was established in more patients with the CFS 48 hour results than with the 24 hour results.
Despite strong correlations between oesophageal acid exposure recorded with the two devices, the Bravo CFS significantly under recorded acid exposure compared with the CPHMS. Provided some correcting factors are used, the Bravo CFS can improve the sensitivity of pHmetry for the diagnosis of GORD by allowing more prolonged recordings.
食管pH监测是诊断胃食管反流病(GORD)的一项有用检查,但与鼻咽电极相关存在一些局限性。最近,一种无遥测导管系统(CFS)(Bravo;美敦力公司)被研发出来。本研究的目的是确定传统pH测量系统(CPHMS)与CFS Bravo之间数据的一致性。
40例有GORD症状提示的患者同时使用带有鼻咽电极的CPHMS和Bravo CFS进行24小时食管pH监测。在荧光透视下将两个电极的敏感尖端置于同一水平。除自动分析外,对每一次反流发作进行目视检查并进行特征描述。
CPHMS和CFS记录的24小时食管酸暴露量之间存在显著相关性(r = 0.87,p < 0.0001)。CFS记录的24小时食管酸暴露量显著低于CPHMS(2.4(0.4 - 8.7)对3.6(0.7 - 8.6);p < 0.0001)。因此,使用CFS时,根据回归方程计算出的GORD诊断临界值为2.9%(而CPHMS在对照组中确定的临界值为4.2%)。经过此调整后,GORD诊断的一致性为88%(kappa值为0.760)。与24小时结果相比,更多患者根据CFS的48小时结果确诊为GORD。
尽管两种设备记录的食管酸暴露量之间有很强的相关性,但与CPHMS相比,Bravo CFS记录的酸暴露量明显偏低。如果使用一些校正因素,Bravo CFS通过允许更长时间的记录可提高pH测量法对GORD诊断的敏感性。